The FDA has approved Eli Lilly’s Mounjaro (tirzepatide) injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. The approval marks the first new class of drugs for type 2 diabetes in 10 years.
Source: Drug Industry Daily